Status:
RECRUITING
The Role of Lipid Transporter MFSD2A in the Resolution of Colorectal Cancer-associated Inflammation
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The intrinsic connection between inflammation and tumor promotion is well characterized and is a key pathogenic event in patients with colorectal cancer (CRC), the second most common cause of tumor-re...
Eligibility Criteria
Inclusion
- \- 15 CRC-affected patients stratified according to tumor stage (T0/T1-T4, M0/M1, N0/N1/N2)
Exclusion
- Patients:
- taking trace elements, hypolipemiants in the previous 3 months
- undergone previous intestinal resection
Key Trial Info
Start Date :
March 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 15 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06071598
Start Date
March 15 2023
End Date
March 15 2026
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Ospedale San Raffaele
Milan, Italy